Lethbridge Herald: Grant to help U of L-API partnership develop COVID-19 treatment

07/16/2020
University of Lethbridge researchers, in partnership with scientists at Applied Pharmaceutical Innovation (API), have received funding from MITACS to develop a drug to treat the SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic.

The research team includes U of L’s Trushar Patel and Borries Demeler (Department of Chemistry and Biochemistry), University of Alberta’s Neal Davies (Faculty of Pharmacy and Pharmaceutical Sciences), and API’s Rakesh Bhat (Director of Laboratory Science). API is an Edmonton-based, non-profit organization that partners with industry and supports researchers and start-ups. These researchers are combining forces to make the best use of their equipment and expertise in a bid to develop a new treatment for COVID-19.

Read more...

 

 


Media Contact

Heather Young
Director, Communications
604-818-0020 | hyoung@mitacs.ca

Mitacs

ErinRose Handy
Manager, Communications
604-822-4476 | ehandy@mitacs.ca

Mitacs